Revolutionizing Nuclear Imaging: Positron Corporation’s Groundbreaking Affinity PET-CT 4D Device Set to Make Waves in Clinical Study
Niagara Falls, NY, Dec. 20, 2022 (GLOBE NEWSWIRE) — Positron Corporation (“Positron” or the “Company”) (OTC: POSC), a nuclear medicine PET imaging systems and clinical services company, is pleased to announce the Company’s collaboration with Dr. Bober and Ochsner Health, the largest non-profit, academic healthcare system operating in Louisiana, for the clinical study of Positron’s…